| The mechanisms of atrial fibrillation in hyperthyroidism A Bielecka-Dabrowa, DP Mikhailidis, J Rysz, M Banach Thyroid research 2, 1-7, 2009 | 152 | 2009 |
| Takotsubo cardiomyopathy—the current state of knowledge A Bielecka-Dabrowa, DP Mikhailidis, S Hannam, J Rysz, M Michalska, ... International journal of cardiology 142 (2), 120-125, 2010 | 111 | 2010 |
| Cachexia, muscle wasting, and frailty in cardiovascular disease A Bielecka‐Dabrowa, N Ebner, MR Dos Santos, J Ishida, G Hasenfuss, ... European journal of heart failure 22 (12), 2314-2326, 2020 | 100 | 2020 |
| The role of polyphenols in cardiovascular disease M Michalska, A Gluba, DP Mikhailidis, P Nowak, A Bielecka-Dabrowa, ... Med Sci Monit 16 (5), RA110-9, 2010 | 93 | 2010 |
| HSP 70 and atherosclerosis–protector or activator? A Bielecka-Dabrowa, M Barylski, DP Mikhailidis, J Rysz, M Banach Expert Opinion on Therapeutic Targets 13 (3), 307-317, 2009 | 93 | 2009 |
| The meaning of hypokalemia in heart failure A Bielecka-Dabrowa, DP Mikhailidis, L Jones, J Rysz, WS Aronow, ... International Journal of Cardiology 158 (1), 12-17, 2012 | 85 | 2012 |
| The rise and fall of hypertension: lessons learned from Eastern Europe A Bielecka-Dabrowa, WS Aronow, J Rysz, M Banach Current cardiovascular risk reports 5, 174-179, 2011 | 75 | 2011 |
| The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy A Bielecka-Dabrowa, JH Goch, DP Mikhailidis, J Rysz, M Maciejewski, ... Medical science monitor 15 (12), MS12-MS23, 2009 | 75 | 2009 |
| Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview M Michalska-Kasiczak, A Bielecka-Dabrowa, S Von Haehling, SD Anker, ... Archives of Medical Science 14 (4), 890-909, 2018 | 72 | 2018 |
| Malignancy-associated dyslipidemia A Bielecka-Dąbrowa, S Hannam, J Rysz, M Banach The open cardiovascular medicine journal 5, 35, 2011 | 71 | 2011 |
| Heart failure biomarkers in patients with dilated cardiomyopathy A Bielecka-Dabrowa, S von Haehling, WS Aronow, MI Ahmed, J Rysz, ... International journal of cardiology 168 (3), 2404-2410, 2013 | 63 | 2013 |
| The effects of statins on blood pressure in normotensive or hypertensive subjects—a meta-analysis of randomized controlled trials M Banach, S Nikfar, R Rahimi, A Bielecka-Dabrowa, MJ Pencina, ... International journal of cardiology 168 (3), 2816-2824, 2013 | 59 | 2013 |
| The effects of statins on blood pressure in normotensive or hypertensive subjects—a meta-analysis of randomized controlled trials M Banach, S Nikfar, R Rahimi, A Bielecka-Dabrowa, MJ Pencina, ... International journal of cardiology 168 (3), 2816-2824, 2013 | 59 | 2013 |
| The multi-biomarker approach for heart failure in patients with hypertension A Bielecka-Dabrowa, A Gluba-Brzózka, M Michalska-Kasiczak, M Misztal, ... International journal of molecular sciences 16 (5), 10715-10733, 2015 | 55 | 2015 |
| Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies A Bielecka-Dabrowa, A Sakowicz, M Misztal, S von Haehling, A Ahmed, ... International journal of cardiology 221, 1073-1080, 2016 | 49 | 2016 |
| Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) AFG Cicero, A Colletti, S von Haehling, D Vinereanu, ... Nutrition research reviews 33 (1), 155-179, 2020 | 48 | 2020 |
| Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis A Bielecka-Dabrowa, I Bytyçi, S Von Haehling, S Anker, J Jozwiak, J Rysz, ... Lipids in health and disease 18 (1), 1-13, 2019 | 44 | 2019 |
| Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function A Bielecka-Dabrowa, B Godoy, T Suzuki, M Banach, S von Haehling Clinical Research in Cardiology 108, 225-233, 2019 | 44 | 2019 |
| The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis M Banach, J Lewek, S Surma, PE Penson, A Sahebkar, SS Martin, ... European journal of preventive cardiology 30 (18), 1975-1985, 2023 | 42 | 2023 |
| The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy–5-year follow-up A Bielecka-Dabrowa, DP Mikhailidis, M Rizzo, S Von Haehling, J Rysz, ... Lipids in health and disease 12, 1-12, 2013 | 37 | 2013 |
